Xponance’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Xponance's PGEN Position: Q2 2026 in Review
Xponance increased its Precigen (PGEN) stake by 14% in Q2 2026, buying an estimated $9.61K and bringing the position to 18,575 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.
Xponance first reported a position in PGEN in Q2 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Xponance held 18,575 shares of Precigen worth $106K as of Q2 2026.
- Xponance bought 2,223 Precigen shares in Q2 2026, an estimated $9.61K.
- Precigen made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1720 holding.
- Xponance first reported a position in Precigen in Q2 2025 and has held it in 5 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.